{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T03:21:32Z","timestamp":1771644092395,"version":"3.50.1"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,11,23]],"date-time":"2020-11-23T00:00:00Z","timestamp":1606089600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,11,23]],"date-time":"2020-11-23T00:00:00Z","timestamp":1606089600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Retin Vitr"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>Blood is one of the main absorbers in the near-infrared spectrum and thus retinal vessels appear dark in near-infrared reflectance (NIR) images. Proliferative diabetic retinopathy (PDR) is characterized by abnormal neovascularization which also absorbs light and appears dark against a lighter fundus background. We analyzed neovascularization in PDR using NIR imaging, by observing changes in the neovascular complexes (NVCs) contrast and reflectivity over time.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Methods<\/jats:title>\n<jats:p>Retrospective case series of 20 eyes of 17 patients with PDR who underwent NIR imaging with optical coherence tomography (OCT) using the Spectralis System. NVCs presence and activity was determined using clinical, tomographic and angiographic criteria. At baseline, all NVCs were qualitatively graded in the NIR image into 3 groups (absent, present and inactive and present and active) and their evolution over time was registered as progression, regression or same status.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Results<\/jats:title>\n<jats:p>Twenty-seven NVCs were imaged, of which, 52% were neovascularization of the disc (NVD) and 48% were elsewhere (NVE). Consecutive NIR images were obtained from baseline to up to 5 time-points with a mean follow-up of 3.2\u2009\u00b1\u20091.7\u00a0years. All eyes underwent laser treatment and 30% had additional intravitreal therapy. Using NIR imaging, NVCs were classified at baseline as absent, present and inactive and present and active, respectively in 11, 4 and 85% of cases. NIR identified active neovascularization as hyporeflective irregular dark vessels originating from the retinal venules in NVE or from the disc in NVD. In all groups during follow-up, progression was identified as the development of new vascular hyporeflective dark fronds while regression was shown by reduced dark perfusion. Five eyes developed a wolf\u2019s jaw configuration with vascular hyporeflective new vessels and hyperreflective tissue from extensive fibrosis. Fibrosis was more apparent in later images, reaching 86%. In 3 cases (11%), the NVC was no longer seen in NIR, although was still identifiable on OCT over the NVC area.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Conclusions<\/jats:title>\n<jats:p>NIR is a non-invasive imaging modality commonly performed alongside OCT and frequently overlooked which can be useful to evaluate NVCs in PDR. Changes in NVC contrast and reflectivity due to blood perfusion can help in the detection and monitoring of diabetic proliferative disease and aid clinicians in daily practice.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s40942-020-00263-8","type":"journal-article","created":{"date-parts":[[2020,11,23]],"date-time":"2020-11-23T15:10:21Z","timestamp":1606144221000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Near-infrared reflectance imaging of neovascularization in proliferative diabetic retinopathy"],"prefix":"10.1186","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6125-5486","authenticated-orcid":false,"given":"Sara","family":"Vaz-Pereira","sequence":"first","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1843-1701","authenticated-orcid":false,"given":"Manuel","family":"Monteiro-Grillo","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7582-2672","authenticated-orcid":false,"given":"Michael","family":"Engelbert","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2020,11,23]]},"reference":[{"key":"263_CR1","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.2337\/diacare.21.9.1414","volume":"21","author":"H King","year":"1998","unstructured":"King H, Aubert RE, Herman WH. Global burden of diabetes, 1995\u20132025: prevalence, numerical estimates, and projections. Diabetes Care. 1998;21:1414\u201331.","journal-title":"Diabetes Care"},{"key":"263_CR2","doi-asserted-by":"publisher","first-page":"556","DOI":"10.2337\/dc11-1909","volume":"35","author":"JW Yau","year":"2012","unstructured":"Yau JW, Rogers SL, Kawasaki R, et al. Global prevalence and major risk factors of diabetic retinopathy. Diabetes Care. 2012;35:556\u201364.","journal-title":"Diabetes Care"},{"key":"263_CR3","first-page":"471","volume":"96","author":"DB Archer","year":"1976","unstructured":"Archer DB. Neovascularization of the retina. Trans Ophthalmol Soc U K. 1976;96:471\u201393.","journal-title":"Trans Ophthalmol Soc U K"},{"key":"263_CR4","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1016\/B978-1-4557-0737-9.00048-5","volume-title":"Ryan's retina","author":"PAS Silva","year":"2013","unstructured":"Silva PAS, Cavallerano JD, Sun JK. Proliferative diabetic retinopathy. In: Sadda SR, editor. Ryan\u2019s retina. London: Elsevier Saunders; 2013. p. 969\u20131000."},{"key":"263_CR5","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1111\/ceo.12711","volume":"44","author":"ED Cole","year":"2016","unstructured":"Cole ED, Novais EA, Louzada RN, et al. Contemporary retinal imaging techniques in diabetic retinopathy: a review. Clin Exp Ophthalmol. 2016;44:289\u201399.","journal-title":"Clin Exp Ophthalmol"},{"key":"263_CR6","first-page":"1","volume":"21","author":"Diabetic retinopathy study","year":"1981","unstructured":"Diabetic retinopathy study. Report Number 6. Design, methods, and baseline results. Report Number 7. A modification of the Airlie House classification of diabetic retinopathy. Prepared by the Diabetic Retinopathy. Invest Ophthalmol Vis Sci. 1981;21:1\u2013226.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"263_CR7","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1016\/S0161-6420(13)38012-9","volume":"98","author":"Early Treatment Diabetic Retinopathy Study Research Group","year":"1991","unstructured":"Early Treatment Diabetic Retinopathy Study Research Group. Grading diabetic retinopathy from stereoscopic color fundus photographs\u2013an extension of the modified Airlie House classification. ETDRS report number 10. Ophthalmology. 1991;98:786\u2013806.","journal-title":"Ophthalmology"},{"key":"263_CR8","first-page":"108","volume":"63","author":"EW Norton","year":"1965","unstructured":"Norton EW, Gutman F. Diabetic retinopathy studied by fluorescein angiography. Trans Am Ophthalmol Soc. 1965;63:108\u201328.","journal-title":"Trans Am Ophthalmol Soc"},{"key":"263_CR9","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1001\/archopht.1968.00980050585004","volume":"80","author":"JD Gass","year":"1968","unstructured":"Gass JD. A fluorescein angiographic study of macular dysfunction secondary to retinal vascular disease. IV. Diabetic retinal angiopathy. Arch Ophthalmol. 1968;80:583\u201391.","journal-title":"Arch Ophthalmol"},{"key":"263_CR10","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1097\/IAE.0b013e3182753b6f","volume":"33","author":"H Cho","year":"2013","unstructured":"Cho H, Alwassia AA, Regiatieri CV, et al. Retinal neovascularization secondary to proliferative diabetic retinopathy characterized by spectral domain optical coherence tomography. Retina. 2013;33:542\u20137.","journal-title":"Retina"},{"key":"263_CR11","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1136\/bjophthalmol-2013-303941","volume":"98","author":"MM Muqit","year":"2014","unstructured":"Muqit MM, Stanga PE. Fourier-domain optical coherence tomography evaluation of retinal and optic nerve head neovascularisation in proliferative diabetic retinopathy. Br J Ophthalmol. 2014;98:65\u201372.","journal-title":"Br J Ophthalmol"},{"key":"263_CR12","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1136\/bjophthalmol-2013-304452","volume":"98","author":"MM Muqit","year":"2014","unstructured":"Muqit MM, Stanga PE. Swept-source optical coherence tomography imaging of the cortical vitreous and the vitreoretinal interface in proliferative diabetic retinopathy: assessment of vitreoschisis, neovascularisation and the internal limiting membrane. Br J Ophthalmol. 2014;98:994\u20137.","journal-title":"Br J Ophthalmol"},{"key":"263_CR13","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1097\/IAE.0000000000000869","volume":"36","author":"S Vaz-Pereira","year":"2016","unstructured":"Vaz-Pereira S, Zarranz-Ventura J, Sim DA, et al. Optical coherence tomography features of active and inactive retinal neovascularization in proliferative diabetic retinopathy. Retina. 2016;36:1132\u201342.","journal-title":"Retina"},{"key":"263_CR14","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1097\/IAE.0000000000001336","volume":"37","author":"S Vaz-Pereira","year":"2017","unstructured":"Vaz-Pereira S, Dansingani KK, Chen KC, et al. Tomographic relationships between retinal neovascularization and the posterior vitreous in proliferative diabetic retinopathy. Retina. 2017;37:1287\u201396.","journal-title":"Retina"},{"key":"263_CR15","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s40942-020-00230-3","volume":"6","author":"S Vaz-Pereira","year":"2020","unstructured":"Vaz-Pereira S, Morais-Sarmento T, Esteves Marques R. Optical coherence tomography features of neovascularization in proliferative diabetic retinopathy: a systematic review. Int J Retina Vitreous. 2020;6:26.","journal-title":"Int J Retina Vitreous"},{"key":"263_CR16","doi-asserted-by":"publisher","first-page":"35-44.e1","DOI":"10.1016\/j.ajo.2015.04.021","volume":"160","author":"A Ishibazawa","year":"2015","unstructured":"Ishibazawa A, Nagaoka T, Takahashi A, et al. Optical coherence tomography angiography in diabetic retinopathy: a prospective pilot study. Am J Ophthalmol. 2015;160:35\u201344.e1.","journal-title":"Am J Ophthalmol"},{"key":"263_CR17","doi-asserted-by":"publisher","first-page":"2371","DOI":"10.1097\/IAE.0000000000000716","volume":"35","author":"TS Hwang","year":"2015","unstructured":"Hwang TS, Jia Y, Gao SS, et al. Optical coherence tomography angiography features of diabetic retinopathy. Retina. 2015;35:2371\u20136.","journal-title":"Retina"},{"key":"263_CR18","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1159\/000442802","volume":"56","author":"PE Stanga","year":"2016","unstructured":"Stanga PE, Papayannis A, Tsamis E, et al. New findings in diabetic maculopathy and proliferative disease by swept-source optical coherence tomography angiography. Dev Ophthalmol. 2016;56:113\u201321.","journal-title":"Dev Ophthalmol"},{"key":"263_CR19","doi-asserted-by":"publisher","first-page":"528\u2013538.e3","DOI":"10.1016\/j.ajo.2014.12.002","volume":"159","author":"M Miura","year":"2015","unstructured":"Miura M, Hong YJ, Yasuno Y, et al. Three-dimensional vascular imaging of proliferative diabetic retinopathy by Doppler optical coherence tomography. Am J Ophthalmol. 2015;159:528\u2013538.e3.","journal-title":"Am J Ophthalmol"},{"key":"263_CR20","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/s11892-016-0811-x","volume":"16","author":"J Lee","year":"2016","unstructured":"Lee J, Rosen R. Optical coherence tomography angiography in diabetes. Curr Diab Rep. 2016;16:123.","journal-title":"Curr Diab Rep"},{"key":"263_CR21","doi-asserted-by":"publisher","first-page":"3351","DOI":"10.2147\/OPTH.S274537","volume":"14","author":"S Vaz-Pereira","year":"2020","unstructured":"Vaz-Pereira S, Silva JJ, Freund KB, et al. Optical coherence tomography angiography features of neovascularization in proliferative diabetic retinopathy. Clin Ophthalmol. 2020;14:3351\u201362.","journal-title":"Clin Ophthalmol"},{"key":"263_CR22","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/0042-6989(95)00100-E","volume":"36","author":"AE Elsner","year":"1996","unstructured":"Elsner AE, Burns SA, Weiter JJ, et al. Infrared imaging of sub-retinal structures in the human ocular fundus. Vision Res. 1996;36:191\u2013205.","journal-title":"Vision Res"},{"key":"263_CR23","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/S0161-6420(96)30731-8","volume":"103","author":"ME Hartnett","year":"1996","unstructured":"Hartnett ME, Elsner AE. Characteristics of exudative age-related macular degeneration determined in vivo with confocal and indirect infrared imaging. Ophthalmology. 1996;103:58\u201371.","journal-title":"Ophthalmology"},{"key":"263_CR24","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1007\/s00417-009-1148-9","volume":"247","author":"T Theelen","year":"2009","unstructured":"Theelen T, Berendschot TT, Hoyng CB, et al. Near-infrared reflectance imaging of neovascular age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol. 2009;247:1625\u201333.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"263_CR25","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/978-3-540-85540-8_8","volume-title":"Medical retina: focus on retinal imaging","author":"T Theelen","year":"2010","unstructured":"Theelen T, Hoyng CB, Klevering BJ. Near-infrared subretinal imaging in choroidal neovascularization. In: Holz FG, Spaide RF, editors. Medical retina: focus on retinal imaging. Berlin: Springer; 2010. p. 77\u201391."},{"key":"263_CR26","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/S1350-9462(02)00060-5","volume":"22","author":"TT Berendschot","year":"2003","unstructured":"Berendschot TT, DeLint PJ, van Norren D. Fundus reflectance\u2013historical and present ideas. Prog Retin Eye Res. 2003;22:171\u2013200.","journal-title":"Prog Retin Eye Res"},{"key":"263_CR27","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1007\/s004170050383","volume":"237","author":"A Remky","year":"1999","unstructured":"Remky A, Beausencourt E, Hartnett ME, et al. Infrared imaging of cystoid macular edema. Graefes Arch Clin Exp Ophthalmol. 1999;237:897\u2013901.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"263_CR28","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1016\/j.oftal.2018.06.023","volume":"94","author":"S Vaz-Pereira","year":"2019","unstructured":"Vaz-Pereira S, Monteiro-Grillo M, Engelbert M. Proliferative diabetic retinopathy imaged by near-infrared reflectance. Arch Soc Esp Oftalmol. 2019;94:e1.","journal-title":"Arch Soc Esp Oftalmol"},{"key":"263_CR29","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1016\/S0161-6420(13)38011-7","volume":"98","author":"Early Treatment Diabetic Retinopathy Study Research Group","year":"1991","unstructured":"Early Treatment Diabetic Retinopathy Study Research Group. Early photocoagulation for diabetic retinopathy ETDRS report number 9. Ophthalmology. 1991;98:766\u201385.","journal-title":"Ophthalmology"},{"key":"263_CR30","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1038\/s41433-019-0628-3","volume":"34","author":"F He","year":"2020","unstructured":"He F, Yu W. Longitudinal neovascular changes on optical coherence tomography angiography in proliferative diabetic retinopathy treated with panretinal photocoagulation alone versus with intravitreal conbercept plus panretinal photocoagulation: a pilot study. Eye. 2020;34:1413\u20138.","journal-title":"Eye"},{"key":"263_CR31","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1001\/jamaophthalmol.2018.3255","volume":"136","author":"JG Gross","year":"2018","unstructured":"Gross JG, Glassman AR, Liu D, et al. Five-year outcomes of panretinal photocoagulation vs intravitreous ranibizumab for proliferative diabetic retinopathy: a randomized clinical trial. JAMA Ophthalmol. 2018;136:1138\u201348.","journal-title":"JAMA Ophthalmol"},{"key":"263_CR32","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1016\/S0161-6420(84)34125-2","volume":"91","author":"K Muraoka","year":"1984","unstructured":"Muraoka K, Shimizu K. Intraretinal neovascularization in diabetic retinopathy. Ophthalmology. 1984;91:1440\u20136.","journal-title":"Ophthalmology"},{"key":"263_CR33","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1016\/S0161-6420(13)38014-2","volume":"98","author":"Early Treatment Diabetic Retinopathy Study Research Group","year":"1991","unstructured":"Early Treatment Diabetic Retinopathy Study Research Group. Fundus photographic risk factors for progression of diabetic retinopathy ETDRS report number 12. Ophthalmology. 1991;98:823\u201333.","journal-title":"Ophthalmology"},{"key":"263_CR34","first-page":"136","volume":"37","author":"Y Sato","year":"1993","unstructured":"Sato Y, Kamata A, Matsui M. Clinical study of venous abnormalities in diabetic retinopathy. Jpn J Ophthalmol. 1993;37:136\u201342.","journal-title":"Jpn J Ophthalmol"},{"key":"263_CR35","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/S0161-6420(93)31666-0","volume":"100","author":"S Kishi","year":"1993","unstructured":"Kishi S, Shimizu K. Clinical manifestations of posterior precortical vitreous pocket in proliferative diabetic retinopathy. Ophthalmology. 1993;100:225\u20139.","journal-title":"Ophthalmology"},{"key":"263_CR36","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1007\/s004170100261","volume":"239","author":"R Lattanzio","year":"2001","unstructured":"Lattanzio R, Brancato R, Bandello FM, et al. Florid diabetic retinopathy (FDR): a long-term follow-up study. Graefes Arch Clin Exp Ophthalmol. 2001;239:182\u20137.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"263_CR37","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.exer.2015.04.004","volume":"142","author":"S Roy","year":"2016","unstructured":"Roy S, Amin S, Roy S. Retinal fibrosis in diabetic retinopathy. Exp Eye Res. 2016;142:71\u20135.","journal-title":"Exp Eye Res"},{"key":"263_CR38","first-page":"440","volume":"69","author":"JW McMeel","year":"1971","unstructured":"McMeel JW. Diabetic retinopathy: fibrotic proliferation and retinal detachment. Trans Am Ophthalmol Soc. 1971;69:440\u201393.","journal-title":"Trans Am Ophthalmol Soc"}],"container-title":["International Journal of Retina and Vitreous"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40942-020-00263-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s40942-020-00263-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40942-020-00263-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,23]],"date-time":"2020-11-23T15:55:25Z","timestamp":1606146925000},"score":1,"resource":{"primary":{"URL":"https:\/\/journalretinavitreous.biomedcentral.com\/articles\/10.1186\/s40942-020-00263-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,23]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["263"],"URL":"https:\/\/doi.org\/10.1186\/s40942-020-00263-8","relation":{},"ISSN":["2056-9920"],"issn-type":[{"value":"2056-9920","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,23]]},"assertion":[{"value":"12 July 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 November 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 November 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by Centro Hospitalar Universit\u00e1rio de Lisboa Norte, EPE\u2014Hospital de Santa Maria local ethics committee (Lisbon, Portugal) and was conducted in accordance with the ethical principles of the Declaration of Helsinki. Informed consent was obtained from all participants.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All participants consented to the use of their anonymized data.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"SVP reports consultant fees from Alimera Sciences, Bayer, Novartis and Roche. MMG has nothing to disclose. ME is a consultant for Genentech, Bayer, Allergan and Alimera Sciences.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"59"}}